5 in India
Viruj is a fast-emerging API manufacturer with global presence and an objective to develop & market complex, technology-driven APIs
Tacrolimus
Immunosuppressants decrease the effects of your body’s immune system
Tacrolimus
Astellas Pharma India Pvt Ltd, the Indian subsidiary of the Japan's second largest drug major, Astellas Pharma, is working on a marketing strategy of spreading public
PROGRAF is a prescription medicine used with
We are manufacturer Tacrolimus 1mg Capsule - Prograf 1mg Capsule-Prograf 1mg Capsule is used along with other medicines to
Drug Name : Tacrolimus Tacrolimus (Prograf) generic is an immunosuppressant, prescribed for preventing organ rejection during transplantation
PROGRAF(tacrolimus): Learn about PROGRAF's Dosage, Side Effects and indications 17
Hsn Code
PROGRAF 1mg Hard Capsule 10's Choose Generic substitutes to Save up to 50% off Immune Suppression Rx required ₹432
94 Price : ₹438 You Save : ₹17 (4%) 10 Capsule (s) In A Strip ADD TO CART
Apollo Pharmacy - Buy Prograf 0
5 mg used for? Tacrolimus 0
Get free medicine home delivery in over 1800 cities across India
24 May 2023
• Increased risk of infection
Corporate Office Address
₹ 550/ Stripe Get Latest Price
Space-saving desktop model
Tacrograf 2 Mg Capsules ₹ 381/ Stripe
: 220, Mahagujarat Industrial Estate, At & Post: Moraiya, Tal – Sanand, Dist
b Eligible participants in the PROGRAF Copay Card Program ("Program") may receive annual savings up to $3000 for PROGRAF
Others
The cost for Prograf intravenous solution (5 mg/mL) is around $2,617 for a supply of 10 milliliters, depending on the
For Production CAD market
India, Nagpur
com New Delhi, India: Tata McGraw Hill Education Private Limited; 2009
MAT Progress, Val ₹ ‘000 Cr
Effects on female reproductive function (parturition) and embryolethal Astellas Pharma India Pvt Ltd, the Indian subsidiary of the Japan's second largest drug major, Astellas Pharma, is working on a marketing strategy of spreading public awareness on organ transplantation and cadever organ donation along with intensive campaign among specialists to establish a market for its flagship immunosuppressant product - Prograf -
India's display panel market is estimated to grow from ~US$ 7 billion in 2021 to US$ 15 billion in 2025